Published in Cardiol J on January 01, 2013
Cardiac MR imaging: current status and future direction. Cardiovasc Diagn Ther (2015) 0.84
Magnetic resonance imaging for characterizing myocardial diseases. Int J Cardiovasc Imaging (2017) 0.76
RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation (2002) 3.93
Competing autonomic mechanisms precede the onset of postoperative atrial fibrillation. J Am Coll Cardiol (2003) 2.92
Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm (2010) 2.89
Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol (2005) 2.80
Significance of follow-up left ventricular ejection fraction measurements in the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation trial (DEFINITE). Heart Rhythm (2013) 2.79
Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation (2011) 2.56
Prevalence of regional myocardial thinning and relationship with myocardial scarring in patients with coronary artery disease. JAMA (2013) 2.29
Angiographic estimates of myocardium at risk during acute myocardial infarction: validation study using cardiac magnetic resonance imaging. Eur Heart J (2007) 2.26
Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. Heart Rhythm (2013) 2.22
Quantitative analysis of parasympathetic innervation of the porcine heart. Heart Rhythm (2010) 2.16
Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor. Neuropsychopharmacology (2007) 2.11
Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications. J Am Coll Cardiol (2008) 2.10
Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT). Circulation (2011) 2.08
Chemical manipulation of hsp70 ATPase activity regulates tau stability. J Neurosci (2009) 2.05
Sudden cardiac death and dialysis patients. Semin Dial (2008) 1.92
Estimation of distribution algorithm for resource allocation in green cooperative cognitive radio sensor networks. Sensors (Basel) (2013) 1.79
Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol (2006) 1.78
Cryptogenic Stroke and underlying Atrial Fibrillation (CRYSTAL AF): design and rationale. Am Heart J (2010) 1.76
Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm (2010) 1.74
Left ventricular function during and after right ventricular pacing. J Am Coll Cardiol (2004) 1.74
Correspondence between the 17-segment model and coronary arterial anatomy using contrast-enhanced cardiac magnetic resonance imaging. JACC Cardiovasc Imaging (2008) 1.70
Pacing-induced heterogeneities in intracellular Ca2+ signaling, cardiac alternans, and ventricular arrhythmias in intact rat heart. Circ Res (2006) 1.66
Accuracy of mode switch algorithms for detection of atrial tachyarrhythmias. J Cardiovasc Electrophysiol (2004) 1.62
Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease. PLoS Med (2009) 1.62
Safety of magnetic resonance imaging of patients with a new Medtronic EnRhythm MRI SureScan pacing system: clinical study design. Trials (2008) 1.60
Myosin-binding protein C phosphorylation, myofibril structure, and contractile function during low-flow ischemia. Circulation (2005) 1.59
Determinants of myocardial salvage during acute myocardial infarction: evaluation with a combined angiographic and CMR myocardial salvage index. JACC Cardiovasc Imaging (2010) 1.57
Unique autonomic profile of the pulmonary veins and posterior left atrium. J Am Coll Cardiol (2007) 1.56
Cryoballoon versus radiofrequency catheter ablation for paroxysmal atrial fibrillation. Pacing Clin Electrophysiol (2015) 1.55
Impact of the Advisa MRI pacing system on the diagnostic quality of cardiac MR images and contraction patterns of cardiac muscle during scans: Advisa MRI randomized clinical multicenter study results. Heart Rhythm (2013) 1.54
Older age is the strongest predictor of postoperative atrial fibrillation. Anesthesiology (2002) 1.49
Targeted nonviral gene-based inhibition of Gα(i/o)-mediated vagal signaling in the posterior left atrium decreases vagal-induced atrial fibrillation. Heart Rhythm (2011) 1.48
Review of the ICD Registry's third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance. Heart Rhythm (2009) 1.46
Implications of pacemakers and implantable cardioverter defibrillators in urological practice. J Urol (2011) 1.45
Effect of electrogram characteristics on the relationship of dominant frequency to atrial activation rate in atrial fibrillation. Heart Rhythm (2006) 1.45
The Cardiac Atlas Project--an imaging database for computational modeling and statistical atlases of the heart. Bioinformatics (2011) 1.44
Assessment of parasympathetic reactivation after exercise. Am J Physiol Heart Circ Physiol (2006) 1.44
High-resolution electrical mapping of depolarization and repolarization alternans in an ischemic dog model. Am J Physiol Heart Circ Physiol (2009) 1.43
Menstrual cycle and ST height. Ann Noninvasive Electrocardiol (2004) 1.42
Trafficking CD11b-positive blood cells deliver therapeutic genes to the brain of amyloid-depositing transgenic mice. J Neurosci (2010) 1.42
Technical considerations for dominant frequency analysis. J Cardiovasc Electrophysiol (2007) 1.40
Review of the Registry's second year, data collected, and plans to add lead and pediatric ICD procedures. Heart Rhythm (2008) 1.38
Frequency gradients during two different forms of fibrillation in the canine atria. Heart Rhythm (2007) 1.38
Cardiology participation improves outcomes in patients with new-onset heart failure in the outpatient setting. J Am Coll Cardiol (2003) 1.38
Review of the registry's first year, data collected, and future plans. Heart Rhythm (2007) 1.35
Increased complication rates of cardiac rhythm management devices in ESRD patients. Am J Kidney Dis (2007) 1.34
Magnetic resonance versus radionuclide pharmacological stress perfusion imaging for flow-limiting stenoses of varying severity. Circulation (2004) 1.33
Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT. Eur Heart J (2010) 1.33
Risk stratification for arrhythmic sudden cardiac death: identifying the roadblocks. Circulation (2011) 1.27
Parasympathetic effects on heart rate recovery after exercise. J Investig Med (2004) 1.21
Multiple defects in intracellular calcium cycling in whole failing rat heart. Circ Heart Fail (2009) 1.20
Mechanisms underlying the formation and dynamics of subcellular calcium alternans in the intact rat heart. Circ Res (2009) 1.19
Rationale and design for the Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation (DETERMINE) trial. J Cardiovasc Electrophysiol (2009) 1.15
Risk stratification for sudden cardiac death: a plan for the future. Circulation (2014) 1.14
Diabetes mellitus and sudden cardiac death: what are the data? Cardiol J (2010) 1.14
Diverse activation of microglia by chemokine (C-C motif) ligand 2 overexpression in brain. J Neuroinflammation (2013) 1.13
A collaborative resource to build consensus for automated left ventricular segmentation of cardiac MR images. Med Image Anal (2013) 1.13
Virtual electrophysiological study in a 3-dimensional cardiac magnetic resonance imaging model of porcine myocardial infarction. J Am Coll Cardiol (2012) 1.09
Understanding and interpreting dominant frequency analysis of AF electrograms. J Cardiovasc Electrophysiol (2007) 1.09
Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients. Heart Rhythm (2006) 1.08
Early repolarization associated with ventricular arrhythmias in patients with chronic coronary artery disease. Circ Arrhythm Electrophysiol (2010) 1.07
Predictors of regional variations in hospitalizations following emergency department visits for atrial fibrillation. Am J Cardiol (2013) 1.07
Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol (2004) 1.06
Atrial fibrillation ablation: location, location, location. J Cardiovasc Electrophysiol (2006) 1.06
The ligament of Marshall as a parasympathetic conduit. Am J Physiol Heart Circ Physiol (2007) 1.06
Dietary fish intake and incident atrial fibrillation (from the Women's Health Initiative). Am J Cardiol (2010) 1.05
Early development of intracellular calcium cycling defects in intact hearts of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol (2010) 1.05
Comparison of effectiveness and safety of ranolazine versus amiodarone for preventing atrial fibrillation after coronary artery bypass grafting. Am J Cardiol (2011) 1.05
Improvements in health-related quality of life before and after isolated cardiac operations. Ann Thorac Surg (2011) 1.03
Autonomic remodeling in the left atrium and pulmonary veins in heart failure: creation of a dynamic substrate for atrial fibrillation. Circ Arrhythm Electrophysiol (2011) 1.03
Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy. Neurobiol Aging (2013) 1.02
Traumatic ventricular septal defect. Ann Thorac Surg (2011) 1.00